CORMEDIX INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CORMEDIX INC. (CRMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.09 million shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-11-05
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 126.75K shares, a 14.93% decline year-over-year.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-06-30 was 580.00K shares, a 582.35% increase year-over-year.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-03-31 was 380.23K shares, a 46.64% increase year-over-year.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-12-31 was 3.00K shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 496.30K shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 1.38M shares, a 55.76% increase from fiscal 2011.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2011 was 886.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2020-09-30 | 126.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 706.75K shares derived: sum of 2 quarters · filed 2020-11-05 | 1.09M shares 10-Q · filed 2020-11-05 | 1.09M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 580.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 960.23K shares 10-Q · filed 2020-08-10 | 963.23K shares derived: sum of 3 quarters · filed 2020-08-10 | 1.11M shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 380.23K shares 10-Q · filed 2020-05-11 | 383.23K shares derived: sum of 2 quarters · filed 2020-05-11 | 532.23K shares derived: sum of 3 quarters · filed 2020-05-11 | 617.23K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 3.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 152.00K shares derived: sum of 2 quarters · filed 2020-03-16 | 237.00K shares derived: sum of 3 quarters · filed 2020-03-16 | 496.30K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 149.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 234.00K shares derived: sum of 2 quarters · filed 2019-11-14 | 493.30K shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 85.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 344.30K shares 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | 259.30K shares 10-Q · filed 2019-05-13 | |||
| 2018-09-30 | 40.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 75.00K shares derived: sum of 2 quarters · filed 2018-11-14 | 663.00K shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 623.00K shares 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | 588.00K shares 10-Q · filed 2018-05-15 | |||
| 2017-09-30 | 85.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 277.50K shares derived: sum of 2 quarters · filed 2017-11-09 | 1.34M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 192.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 1.26M shares 10-Q · filed 2017-08-09 | ||
| 2017-03-31 | 1.06M shares 10-Q · filed 2017-05-10 | |||
| 2012-12-31 | 1.38M shares 10-K/A · filed 2014-03-04 | |||
| 2011-12-31 | 886.00K shares 10-K/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |